This difference in tumor burden has also been observed in a chemically induced model of liver cancer, where caspase-2 deficiency promoted both higher incidence and a significantly increased number of cancerous nodes in the liver after injection with the DNA-alkylating and reactive oxygen species carcinogen Diethylnitrosamine (DEN) (Shalini et al., 2016). This evidence concerns the gene CASP2 and liver cancer.